Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Phase 1 clinical trial of genetically corrected autologous epidermal keratinocytes for recessive dystrophic epidermolysis bullosa Siprashvili, Z., Nguyen, N. T., Gorell, E., Khuu, P., Furukawa, L., Lorenz, H. P., Leung, T. H., Keene, D. R., Khavari, P., Marinkovich, M., Lane, A. T. NATURE PUBLISHING GROUP. 2014: S75
View details for Web of Science ID 000334560400429